Myoglobin and creatine kinase in acute myocardial infarction

Area of Science:

• Cardiology
• Biochemistry
• Medical Diagnostics

Background:

• Acute myocardial infarction (AMI) diagnosis relies on timely biomarkers.
• Early detection of AMI is crucial for effective patient management and improved outcomes.
• Limitations exist in the diagnostic utility of traditional biomarkers like creatine kinase.

Purpose of the Study:

• To compare the diagnostic accuracy of serum myoglobin and creatine kinase in suspected acute myocardial infarction.
• To evaluate the temporal changes in serum myoglobin and creatine kinase levels following symptom onset.
• To determine the optimal time point for single biomarker measurement for AMI diagnosis.

Main Methods:

• Serial measurements of serum myoglobin and creatine kinase activity in patients with suspected AMI.
• Patients were assessed within four hours of symptom onset.
• Diagnostic performance (sensitivity and specificity) was calculated for both biomarkers at various time points.

Main Results:

• Serum myoglobin levels rose earlier and peaked faster than creatine kinase activity in AMI patients.
• At four hours post-symptom onset, myoglobin detected 89% of AMI cases, while creatine kinase detected only 56%.
• A single myoglobin measurement at six hours showed 93% sensitivity and 89% specificity for AMI diagnosis.

Conclusions:

• Serum myoglobin is a more sensitive and earlier biomarker than creatine kinase for diagnosing acute myocardial infarction.
• Myoglobin's rapid rise and fall make it valuable for early rule-out and confirmation of AMI.
• Early assessment of myoglobin levels significantly aids in differentiating patients with and without myocardial infarction.